Furthermore, compared with the absent treatment of berberine, the treatment with berberine significantly increases radiosensitivity in ESCC by blocking VEGF and HIF-1α, which can be clinically applied to radiotherapy resistance [37]. The gene discussed is VEGFA; the disease is esophageal squamous cell carcinoma.